These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15459407)

  • 41. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations.
    Andes D; Craig WA
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():10-7. PubMed ID: 16209701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.
    Tapsall JW; Limnios EA; Murphy D;
    J Antimicrob Chemother; 2008 Jan; 61(1):150-5. PubMed ID: 17986492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical observation of oral cefuroxime axetil for treating acute gonorrhoea].
    Zhang B; Liu Y; Wang J; Wang B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):315-6. PubMed ID: 8575057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic restriction programs and cephalosporin use in pediatrics: a survey of infectious disease specialists.
    Howrie DL; Schwinghammer TL
    Hosp Formul; 1987 Sep; 22(9):797-9, 802. PubMed ID: 10283406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in Botswana.
    Romoren M; Rahman M; Sundby J; Hjortdahl P
    Sex Transm Infect; 2004 Oct; 80(5):395-400. PubMed ID: 15459410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.
    Ghanem KG; Giles JA; Zenilman JM
    Infect Dis Clin North Am; 2005 Jun; 19(2):351-65. PubMed ID: 15963876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.
    Kojima M; Masuda K; Yada Y; Hayase Y; Muratani T; Matsumoto T
    Int J Antimicrob Agents; 2008 Jul; 32(1):50-4. PubMed ID: 18539003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.
    Phillips I
    Drugs; 1987; 34 Suppl 2():164-79. PubMed ID: 3319500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
    Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults.
    Pichichero ME; Casey JR
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):127-30. PubMed ID: 17908614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First four failures of cefathiamidine to treat urogenital gonorrhoea in Guangzhou, China, 2014-15.
    Liang J; Yang R; Li X; Bi C; Ye X; Zhang X; Cao W
    Sex Health; 2017 Jun; 14(3):289-292. PubMed ID: 28384434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guidelines on the treatment of ABRS in adults.
    Benninger M
    Int J Clin Pract; 2007 May; 61(5):873-6. PubMed ID: 17493094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials.
    Bai ZG; Bao XJ; Cheng WD; Yang KH; Li YP
    Int J STD AIDS; 2012 Feb; 23(2):126-32. PubMed ID: 22422688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single dose treatment of acute gonorrhoea with Cefuroxime: experience from Zaria, Nigeria.
    Bello CS; Fakunle YM
    East Afr Med J; 1983 Feb; 60(2):104-7. PubMed ID: 6617543
    [No Abstract]   [Full Text] [Related]  

  • 57. Effective single dose treatment of uncomplicated gonorrhoea.
    Korting HC; Kollmann M
    Int J STD AIDS; 1994; 5(4):239-43. PubMed ID: 7948151
    [No Abstract]   [Full Text] [Related]  

  • 58. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling.
    Blumer JL; Reed MD; Kaplan EL; Drusano GL
    Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changing epidemiological profile and treatment of syphilis and gonorrhea].
    Reunala T; Hiltunen-Back E
    Duodecim; 2002; 118(13):1374-80. PubMed ID: 12239884
    [No Abstract]   [Full Text] [Related]  

  • 60. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
    Nomura K; Morikawa N; Ikawa K; Ikeda K; Fujimoto Y; Shimizu D; Taniguchi K; Shimura K; Kanbayashi Y; Komori T; Matsumoto Y; Fujita N; Shimazaki C; Taniwaki M
    J Antimicrob Chemother; 2008 Apr; 61(4):892-900. PubMed ID: 18276604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.